Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the

Jeffrey J Bajramovic1, Herbert P M Brok, Boudewijn Ouwerling

  • 1Department of Immunobiology, Biomedical Primate Research Centre, Rijswijk, The Netherlands. bajramovic@bprc.nl

Insights

Oligodendrocyte-specific protein (OSP) can trigger experimental autoimmune encephalomyelitis (EAE) in rhesus monkeys, mimicking multiple sclerosis (MS) pathology. Immune responses to OSP cause central nervous system inflammation and optic nerve demyelination.

Area of Science:

  • Neuroimmunology
  • Autoimmunity
  • Demyelinating diseases

Background:

  • Oligodendrocyte-specific protein (OSP) is implicated as an autoantigen in multiple sclerosis (MS).
  • Rhesus monkeys serve as a relevant outbred animal model for MS due to their immunological similarity to humans.

Purpose of the Study:

  • To investigate the encephalitogenic potential of OSP in inducing experimental autoimmune encephalomyelitis (EAE) in rhesus monkeys.
  • To characterize the immune responses and neuropathological outcomes following OSP immunization.

Main Methods:

  • Synthesis of soluble, hydrophilic regions of human OSP (shOSP) for immunization.
  • Induction of EAE in rhesus monkeys via shOSP immunization.
  • Assessment of clinical signs, cellular proliferative responses, antibody production, and neuropathology.

Main Results:

  • Immunization with shOSP induced clinical signs and optic neuritis in 4/10 rhesus monkeys.
  • Clinical disease correlated with strong cellular proliferative responses to shOSP.
  • Neutrophils were identified as playing a significant role in the disease process.
  • All monkeys developed antibodies to OSP peptide 103-123, a known B cell epitope in MS patients.

Conclusions:

  • Immune responses targeting OSP are encephalitogenic in rhesus monkeys, causing CNS inflammation and optic nerve demyelination.
  • OSP is a potential target autoantigen for MS.
  • Antibody responses to OSP peptide 103-123 may serve as a biomarker for OSP immunoreactivity.